Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort-Reference-Cited by-同舟云学术

Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort

Published:2017-12-22 Issue:4 Volume:19 Page:252-260
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Roen A¹,Laut K²,Pelchen-Matthews A¹,Borodulina E³,Caldeira L⁴,Clarke A⁵,Clotet B⁶,d'Arminio Monforte A⁷,Fätkenheuer G⁸,Gatell Artigas JM⁹,Karpov I¹⁰,Kuznetsova A¹¹,Kyselyova G¹²,Mozer-Lisewska I¹³,Mulcahy F¹⁴,Ragone L¹⁵,Scherrer A¹⁶,Uzdaviniene V¹⁷,Vandekerckhove L¹⁸,Vannappagari V¹⁵,Ostergaard L¹⁹,Mocroft A¹,

Affiliation:

1. University College London; London UK

2. University of Copenhagen; Copenhagen Denmark

3. Samara State Medical University; Samara Russia

4. Hospital Santa Maria; Lisbon Portugal

5. Royal Sussex County Hospital; Brighton UK

6. Hospital Universitari Germans Trias i Pujol; Barcelona Spain

7. Ospedale San Paulo; Milan Italy

8. University Hospital Cologne; Cologne Germany

9. Hospital Clinic; Barcelona Spain

10. Belarus State Medical University; Minsk Belarus

11. Kharkov State Medical University; Khrakov Ukraine

12. Crimean Republican AIDS Centre; Simferopol Ukraine

13. Poznan University of Medical Sciences; Poznań Poland

14. St James’ Hospital; Dublin Ireland

15. ViiV Healthcare; Research Triangle Park NC USA

16. University Hospital Zürich; Zürich Switzerland

17. Vilnius University Hospital Santariskiu Klinikos; Vilnius Lithuania

18. Ghent University Hospital; Gent Belgium

19. Aarhus University Hospital; Skejby Denmark

Funder

Seventh Framework Programme

Bristol-Myers Squibb

Gilead Sciences

GlaxoSmithKline LLC

Janssen Research and Development

Merck

Pfizer

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Danmarks Grundforskningsfond

ViiV Healthcare

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hiv.12573/fullpdf

Reference31 articles.

1. HLA-B*5701 screening for hypersensitivity to abacavir;Mallal;N Engl J Med,2008

2. Abacavir hypersensitivity reaction;Hewitt;Clin Infect Dis,2002

3. Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort Study;Rauch;Antivir Ther,2008

4. Hypersensitivity reactions to HIV therapy;Chaponda;Br J Clin Pharmacol,2011

5. The abacavir hypersensitivity reaction: a review;Clay;Clin Ther,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why drug exposure is frequently associated with T-cell mediated cutaneous hypersensitivity reactions;Frontiers in Toxicology;2023-09-19

2. Abacavir Hypersensitivity Reaction Reporting Rates During a Decade ofHLA‐B*5701 Screening as a Risk‐Mitigation Measure;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2018-12-11